Theratechnologies Inc. (TSE:TH – Get Free Report) traded down 4.9% during trading on Friday. The company traded as low as C$4.36 and last traded at C$4.47. 35,472 shares were traded during trading, a decline of 53% from the average session volume of 75,081 shares. The stock had previously closed at C$4.70.
Theratechnologies Price Performance
The company has a debt-to-equity ratio of -180.46, a quick ratio of 0.64 and a current ratio of 1.19. The firm’s fifty day moving average is C$4.47 and its two-hundred day moving average is C$4.47. The company has a market cap of C$205.53 million, a P/E ratio of -23.53, a P/E/G ratio of -8.50 and a beta of 0.26.
Theratechnologies Company Profile
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.
Recommended Stories
- Five stocks we like better than Theratechnologies
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Theratechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies and related companies with MarketBeat.com's FREE daily email newsletter.
